Gut microbiota-derived metabolites in CRC progression and causation Nishu DalalRekha JalandraAnil Kumar Review – Cancer Research 17 July 2021 Pages: 3141 - 3155
Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia Jielun LuShuyi ChenLihua Xu Original Article – Cancer Research 07 July 2021 Pages: 3157 - 3168
Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival Andreas SchmidtAngela ArmentoJörg Fuchs Original Article – Cancer Research Open access 07 July 2021 Pages: 3169 - 3181
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry Friedemann HoneckerSusanne Huschensthe Initiative Geriatrische Hämatologie und Onkologie (IN-GHO®). Original Article – Cancer Research Open access 26 July 2021 Pages: 3183 - 3194
A tumor microenvironment-related mRNA–ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma Zhendong GaoHan HanHaiquan Chen Original Article – Cancer Research 21 July 2021 Pages: 3195 - 3209
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time Mayu OnoTakaaki ObaKen-ichi Ito Original Article – Cancer Research Open access 09 July 2021 Pages: 3211 - 3224
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression Yiming SuYu ZhangXiaohai Wang Original Article – Cancer Research 14 July 2021 Pages: 3225 - 3243
Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation Yu-Jin WangQing-Wen WangWei-Dong Hu Original Article – Cancer Research 13 July 2021 Pages: 3245 - 3254
Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer Jiaxing SunJing ZhangQiang Li Original Article – Cancer Research Open access 21 July 2021 Pages: 3255 - 3268
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases Francesco CucciaMichele RigoFilippo Alongi Original Article – Cancer Research 15 July 2021 Pages: 3269 - 3277
Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer Zhao YangRong YuWeihu Wang Original Article – Cancer Research 29 July 2021 Pages: 3279 - 3288
Increased interleukin-17A-producing γδT cells predict favorable survival in elderly patients with LUAD and LUSC Kele CuiXinyu MeiMin Cheng Original Article – Cancer Research 29 July 2021 Pages: 3289 - 3298
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1 Fabian M. TroschelHeike PalentaBurkhard Greve Original Article – Cancer Research Open access 22 July 2021 Pages: 3299 - 3312
Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression Jan-Paul GundlachCharlotte HauserAnna Trauzold Original Article – Cancer Research Open access 24 July 2021 Pages: 3313 - 3324
Ernst von Leyden (1832–1910): a pioneer in making oncology a respected medical discipline Peter VoswinckelNils Hansson Original Article – Cancer Research Open access 21 July 2021 Pages: 3325 - 3331
The association of immunosurveillance and distant metastases in colorectal cancer Sven JacobVindi JurinovicFlorian Bösch Original Article – Cancer Research Open access 02 September 2021 Pages: 3333 - 3341
Regulation of prognosis-related Siglecs in the glioma microenvironment Rui MaoLiting ZhouDong Zhou Original Article – Cancer Research 01 September 2021 Pages: 3343 - 3357
Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC) Elizabeth HubscherSlaven SikiricaPaul D’Amico Review – Clinical Oncology Open access 30 August 2021 Pages: 3359 - 3368
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis Michal SternschussRinat YerushalmiHadar Goldvaser Original Article – Clinical Oncology 21 March 2021 Pages: 3369 - 3379
Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries Ljupcho EfremovSemaw Ferede AberaDaniel Medenwald Original Article – Clinical Oncology Open access 20 March 2021 Pages: 3381 - 3390
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046 Slavomir KrajnakThomas DeckerMarcus Schmidt Original Article – Clinical Oncology Open access 20 March 2021 Pages: 3391 - 3400
Self-medication with herbal medicine and breast cancer survival: a prospective monocentric study Wala Ben KridisAhmed MnifAfef Khanfir Original Article – Clinical Oncology 21 March 2021 Pages: 3401 - 3407
Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study Katrina A. KnightIoanna DramiCampbell S. D. Roxburgh Original Article – Clinical Oncology Open access 12 March 2021 Pages: 3409 - 3420
Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine–cisplatin and high dose-intensity MVAC Yongjune LeeYoung Seok KimJae-Lyun Lee Original Article – Clinical Oncology 14 March 2021 Pages: 3421 - 3429
SWI/SNF chromatin remodeling complex alterations in meningioma Corey M. GillJoshua LoewensternRaj K. Shrivastava Original Article – Clinical Oncology 14 March 2021 Pages: 3431 - 3440
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma Qian WangYibin JiangHaiwen Huang Original Article – Clinical Oncology 15 April 2021 Pages: 3441 - 3445
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma Mathilde BarrauKhawla MaouiNicolas Williet Original Article – Clinical Oncology 14 March 2021 Pages: 3447 - 3454
A new glance at the role of traditional medicines in treatment of cancers Meysam ShirzadAlireza Abbassian Letter to the Editor 23 June 2021 Pages: 3455 - 3456
Correction to: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways Tongsen ZhengJiabei WangLianxin Liu Correction 02 February 2021 Pages: 3457 - 3458